BioSpace News Archive

Harmonic Bionics, the robotics company for augmenting human movement, announced today that the University of Houston (UH) has purchased and received a Harmony SHR™ exoskeleton to be used in research being conducted by Dr. Jinsook Roh, assistant professor of Biomedical Engineering at UH, and her team at the Rehabilitation Engineering for Improving Neuromotor control (REIGN) Lab

Aviv Clinics highlights a groundbreaking new study that has been published in Scientific Reports, featuring a promising treatment for long COVID symptoms.

GenomOncology announced that the GenomOncology Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease detection.

Emmaus Life Sciences, Inc. announced the recent engagement of Acorn Management Partners, LLC to provided professional relations and consulting services to build investor awareness of Emmaus.

Sharps Compliance Corp. announced that it has entered into a definitive merger agreement to be acquired by an affiliate of Aurora Capital Partners, a leading middle-market private equity firm.

Medline today announced a $60 million prime vendor partnership with Ohio-based Genesis Healthcare System.

Endogena Therapeutics Inc. announced today that the first patient has been treated in a phase 1/2a clinical study of its lead product, EA-2353, a photoreceptor regeneration treatment for retinitis pigmentosa (RP).

EpicentRx Inc. (“EpicentRx”), is pleased to announce that it has been awarded a $500,000 Therapeutics RFP grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study potential neuroprotective effects of its lead small molecule, RRx-001 in Parkinson’s disease (PD).

The global Hepatitis B Vaccines market size is estimated to be worth US$ 1021.8 million in 2021 and is forecast to a readjusted size of US$ 1159.5 million by 2030 with a CAGR of 1.8% during the forecast period 2022-2030.

The global C-MET & HGF Inhibitors market size is estimated to be worth US$ 2294.7 million in 2021 and is forecast to a readjusted size of US$ 10450 million by 2030 with a CAGR of 23.9% during the forecast period 2022-2030.